Liver Cancer
Hepatocellular carcinoma (HCC) is a primary form of liver cancer that typically arises in individuals with chronic liver disease, often leading to symptoms such as weight loss, abdominal pain, and jaundice.
Advanced Liver Cancer: BAY 3547926 Study
We are investigating the safety and effectiveness of a new drug, BAY 3547926, for people with advanced liver cancer. This study aims to understand how well it works in treating this condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Digestive Oncology
Heverlee, Belgium
Algemeen Ziekenhuis Groeninge
Digestive Oncology
Kortrijk, Belgium
Cliniques Universitaires Saint-Luc
Nuclear Medicine
Sint-Stevens-Woluwe, Belgium
Sponsor: Bayer AG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.